IL-13 signaling in cDC2 is required for systemic anaphylactic responses

Area of Science:

• Immunology
• Allergy Research
• Dermatology

Background:

• Cutaneous allergen sensitization (CAS) initiates atopic dermatitis (AD) and the atopic march, potentially leading to systemic allergies.
• Interleukin-13 (IL-13) is crucial for high-affinity IgE antibody production, but its cellular targets in systemic allergic responses are unclear.

Purpose of the Study:

• To elucidate the role of IL-13 in a murine model linking skin inflammation to systemic anaphylaxis.
• To identify the specific cell types targeted by IL-13 in the generation of high-affinity IgE.

Main Methods:

• Utilized cell-specific deletions of the IL-13 receptor α1 subunit (Il13ra1) in a murine CAS model.
• Employed single-cell transcriptomics to analyze IL-13 signaling effects on dendritic cells.
• Investigated the migration and function of IL-13-licensed dendritic cells in vivo.

Main Results:

• Conventional dendritic cells (cDCs), not T or B cells, are essential IL-13 targets for high-affinity IgE generation.
• IL-13 specifically licenses a CX3CR1high cDC2 subset, enhancing their antigen-presenting capacity (upregulating MHC II, CD301a, CD301b, ICOSL).
• These licensed cDC2s migrate to the spleen, promoting IL-13-producing T follicular helper (T_FH13) cell differentiation and IgE production.

Conclusions:

• An IL-13-cDC2 axis is identified as a critical regulator of the atopic march.
• This pathway explains how skin sensitization leads to systemic allergic responses and IgE production.
• Provides a mechanistic basis for the effectiveness of IL-13-targeted therapies in allergic diseases.